food-and-drug-administration

Documents about food-and-drug-administration

• Food and Drug Law Summer Internship Program: Issues in Food and Drug Law#350208DigitalCommons@USU
• Adaptive Optics Retinal Imaging#303635ClinicalTrials.gov
• Clinical Study to Investigate the Urinary Excretion of N-nitrosodimethylamine (NDMA) After Ranitidine Administration#1032476ClinicalTrials.gov
• CiPA Phase 1 ECG Biomarker Validation Study#897961ClinicalTrials.gov
• US Food and Drug Administration black box warnings: Characteristics of drug classes and adverse effects.#223070NCBI PubMed Central
• Human Perception on Medical Extended Reality Devices#806296ClinicalTrials.gov
• 21 U.S.C. § 393 — Food and Drug Administration#577187US Code (LII)
• Clinical Study to Evaluate Cannabidiol Liver Enzyme Elevations and Drug Interactions#897275ClinicalTrials.gov
• Innovating Federalism in the Life Sciences#484372William & Mary Law School Scholarship Repository
• Antibodies to watch in 2026#4716Europe PMC
• Select Updates for the Premarket Cybersecurity Guidance: Section 524B of the Federal Food, Drug, and Cosmetic Act; Draft Guidance for Industry and Food and Drug Administration Staff; Availability#512269Federal Register
• 21 U.S.C. § 399g — Food and Drug Administration Intercenter Institutes#577201US Code (LII)
• 21 U.S.C. § 379d — Automation of Food and Drug Administration#577267US Code (LII)
• Pharmacist of the Bench#492172ScholarWorks@GSU
• The Paradox of Legal Equivalents and Scientific Equivalence: Reconciling Patent Law's Doctrine of Equivalents with the FDA's Bioequivalence Requirement#306051Scholarly Commons at Boston University School of Law
• Risk assessment of genetically modified food and neoliberalism: An argument for democratizing the regulatory review protocol of the Food and Drug Administration#752626PhilArchive
• 21 U.S.C. § 399i — Food and Drug Administration Working Capital Fund#577203US Code (LII)
• HHSF22316001 — HUMANTOUCH LLC — Department of Health and Human Services ($55,496,180)#601602USAspending
• 75F40118F18001 — GUIDEHOUSE LLP — Department of Health and Human Services ($29,952,108)#602148USAspending
• 75F40118F18001 — EQUINOXYS INC. — Department of Health and Human Services ($23,061,585)#602546USAspending
• Pharmacodynamic Biomarkers to Support Biosimilar Development: PCSK9 Inhibitors#1033163ClinicalTrials.gov
• 21 U.S.C. § 2242 — Foreign offices of the Food and Drug Administration#576861US Code (LII)
• Studi Perbandingan Pengaturan Peredaran Kosmetik Antara Badan Pengawas Obat Dan Makanan Republik Indonesia Dengan Food And Drug Administration Amerika Serikat#1006138Terang : Jurnal Kajian Ilmu Sosial, Politik dan Hukum
• Pharmacodynamic Biomarkers to Support Biosimilar Development: Interleukin-5 Antagonists#907751ClinicalTrials.gov
• 21 CFR Part 16 — Regulatory Hearing Before the Food and Drug Administration#506711Code of Federal Regulations (eCFR)
• 21 U.S.C. § 379dd-2 — Activities of the Food and Drug Administration#577242US Code (LII)
• Discordance in orphan drug approvals between the U.S. Food and Drug Administration and the European Medicines Agency: A retrospective observational analysis.#375307NCBI PubMed Central
• 75F40121F19005 — DELOITTE CONSULTING LLP — Department of Health and Human Services ($86,143,930)#601420USAspending
• 75F40123F19005 — REI SYSTEMS, INC. — Department of Health and Human Services ($48,101,270)#601704USAspending
• 75F40121F19001 — TUNNELL CONSULTING INC — Department of Health and Human Services ($45,537,073)#601750USAspending
• 75F40125F19009 — REI SYSTEMS, INC. — Department of Health and Human Services ($42,806,353)#601792USAspending
• HHSF22316002 — DELOITTE CONSULTING LLP — Department of Health and Human Services ($42,413,226)#601800USAspending
• 75F40120F19002 — DELOITTE & TOUCHE LLP — Department of Health and Human Services ($38,887,161)#601877USAspending
• 75F40121F19002 — REI SYSTEMS, INC. — Department of Health and Human Services ($34,899,957)#601978USAspending
• 75F40122F19004 — REI SYSTEMS, INC. — Department of Health and Human Services ($30,674,111)#602119USAspending
• 75F40126F19009 — TUNNELL CONSULTING INC — Department of Health and Human Services ($27,890,405)#602259USAspending
• 75F40121F19001 — DELOITTE CONSULTING LLP — Department of Health and Human Services ($25,181,678)#602399USAspending
• 75F40120F19001 — IQ SOLUTIONS, INC. — Department of Health and Human Services ($24,423,690)#602445USAspending
• 75F40121F19004 — DELOITTE & TOUCHE LLP — Department of Health and Human Services ($23,871,502)#602485USAspending
• 75F40124F19007 — REI SYSTEMS, INC. — Department of Health and Human Services ($22,325,357)#602594USAspending
• 75F40124F19003 — DELOITTE CONSULTING LLP — Department of Health and Human Services ($21,698,866)#602640USAspending
• 75F40119F19003 — DELOITTE CONSULTING LLP — Department of Health and Human Services ($21,435,433)#602662USAspending
• 75F40120F19004 — DELOITTE CONSULTING LLP — Department of Health and Human Services ($20,774,396)#602723USAspending
• Tobacco, the Food and Drug Administration, and Congress#179781Scholarly Commons at Boston University School of Law
• A Post Marketing Surveillance As Required By Philippine Food And Drug Administration#979391ClinicalTrials.gov
• US Food and Drug Administration Shifts to AI-Enhanced Regulatory Review With Elsa 4.0 and HALO.#244366NCBI PubMed Central
• Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions; Guidance for Industry and Food and Drug Administration Staff; Availability#512214Federal Register
• Regulation And Payment Of New Medical Technologies#167474EliScholar
• Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability#512195Federal Register
• 21 CFR Part 1250 — Interstate Conveyance Sanitation#506938Code of Federal Regulations (eCFR)